```html

Apple‑Jelly Skin Rash

What is Apple-jelly skin rash?

Apple‑jelly skin rash is a descriptive term for a reddish‑brown, translucent or “jelly‑like” appearance that becomes most evident when a skin lesion is pressed with a glass slide (a technique known as diascopy). The color resembles the skin of a peeled green apple, hence the name. The finding is not a disease itself; rather, it is a clinical clue that points to underlying disorders that cause dermal infiltration by inflammatory cells, granulomas, or mucin.

The rash is typically seen on the limbs, torso or face of children and adults alike. Because the appearance can be subtle, health‑care providers often use a dermatoscope or a simple glass slide to confirm the “apple‑jelly” quality. Recognizing this sign helps narrow the differential diagnosis and speeds up appropriate treatment.

Common Causes

Below are the most frequently reported conditions that produce an apple‑jelly‑colored rash:

• Dermatophytosis (tinea corporis) – Fungal infection of the skin.
• Granuloma annulare – A benign, self‑limited granulomatous condition.
• Lupus vulgaris – The cutaneous form of tuberculosis.
• Cutaneous leishmaniasis – Parasitic infection transmitted by sand‑flies.
• Sarcoidosis – Multisystem granulomatous disease that may involve the skin.
• Discoid lupus erythematosus (DLE) – Chronic cutaneous lupus.
• Necrobiosis lipoidica – Often associated with diabetes mellitus.
• Primary cutaneous B‑cell lymphoma – Low‑grade lymphoma of the skin.
• Mycobacterial infection (non‑tuberculous) – e.g., Mycobacterium marinum.
• Dermatofibroma – Benign fibrous nodule that can show a faint apple‑jelly hue.

Associated Symptoms

Apple‑jelly rash rarely appears in isolation. The accompanying clinical picture often helps pinpoint the cause:

• Itching or pruritus – common with fungal infections and some granulomatous disorders.
• Pain or tenderness – may indicate an active infection (e.g., leishmaniasis) or an inflamed lesion.
• Scaling or crusting – typical of tinea corporis.
• Systemic signs such as fever, night sweats, weight loss – raise suspicion for tuberculosis, sarcoidosis or lymphoma.
• Joint pain or swelling – may accompany sarcoidosis or lupus.
• Diabetes or other metabolic disease – often linked with necrobiosis lipoidica.
• Recent travel to endemic areas (e.g., Mediterranean, Middle East) – a clue for leishmaniasis or cutaneous TB.

When to See a Doctor

Most apple‑jelly rashes are not medical emergencies, but early evaluation improves outcomes, especially for infectious or systemic causes. Seek professional care if you notice:

• Lesions that continue to enlarge or change color over a few days.
• Severe itching, burning, or pain that interferes with daily activities.
• Systemic symptoms (fever, chills, weight loss, night sweats).
• Multiple lesions that appear suddenly or spread rapidly.
• A history of recent travel to regions where cutaneous leishmaniasis or tuberculosis is common.
• Any known immune‑compromising condition (HIV, cancer therapy, organ transplant).

Diagnosis

Diagnosing the underlying cause of an apple‑jelly rash involves a stepwise approach:

1. Clinical Examination

• Visual inspection and measurement of lesions.
• Diaskopy: pressing a clear glass slide onto the lesion to reveal the characteristic translucent brown color.
• Dermatoscopy – magnifies vascular patterns and helps differentiate granulomatous lesions from vascular lesions.

2. History Taking

• Onset, duration, progression, and exposure history (travel, animals, soil).
• Past medical problems (diabetes, autoimmune disease, immunosuppression).
• Medication review (some drugs can cause photosensitivity‑related rashes).

3. Laboratory & Imaging Studies

• Skin scraping or KOH prep – to rule out fungal elements.
• Skin biopsy (punch or excisional) – gold standard for granulomatous conditions; histology shows caseating vs. non‑caseating granulomas, presence of organisms, or atypical lymphocytes.
• Special stains (Ziehl‑Neelsen, PAS, GMS) – detect mycobacteria, fungi, or parasites.
• Serologic tests – ANA, anti‑dsDNA for lupus; ACE level for sarcoidosis.
• Chest X‑ray or CT – performed when sarcoidosis or TB is suspected.
• PCR or culture of tissue – especially for leishmaniasis or atypical mycobacteria.

4. Referral

• Dermatology – for ambiguous lesions or when a biopsy is needed.
• Infectious disease – if an infectious etiology is suspected.
• Rheumatology – for systemic autoimmune conditions.

Treatment Options

Treatment is directed at the underlying disease rather than the rash itself. Below are the main therapeutic strategies by cause.

Fungal Infections (Tinea corporis)

• Topical antifungals: clotrimazole, terbinafine, or ketoconazole cream applied twice daily for 2–4 weeks.
• Oral agents (if extensive): terbinafine 250 mg daily or itraconazole 200 mg BID for 2–4 weeks.

Granuloma Annulare

• Observation – many lesions resolve spontaneously.
• Topical or intralesional steroids for symptomatic lesions.
• Low‑dose systemic steroids or tetracycline antibiotics (e.g., doxycycline 100 mg BID) for widespread disease.

Lupus Vulgaris (Cutaneous TB)

• Standard anti‑tubercular therapy (ATT): 2‑month intensive phase (isoniazid, rifampin, pyrazinamide, ethambutol) followed by 4‑month continuation phase (isoniazid + rifampin).
• Adjunctive topical steroids to reduce inflammation after bacterial control.

Cutaneous Leishmaniasis

• Local therapy – intralesional meglumine antimoniate or topical paromomycin.
• Systemic therapy (for multiple or large lesions): oral miltefosine or liposomal amphotericin B.

Sarcoidosis

• First‑line: topical or intralesional corticosteroids for isolated skin lesions.
• Systemic therapy (if multi‑organ involvement): oral prednisone 20–40 mg daily with taper, or steroid‑sparing agents such as methotrexate, azathioprine, or hydroxychloroquine.

Discoid Lupus Erythematosus

• Sun protection + topical steroids or calcineurin inhibitors.
• Systemic antimalarials (hydroxychloroquine 200–400 mg daily) for resistant disease.

Necrobiosis Lipoidica

• Topical high‑potency steroids or tacrolimus.
• Systemic options: low‑dose oral prednisone or pentoxifylline.
• Consider laser therapy or skin grafting for ulcerated lesions.

Primary Cutaneous B‑cell Lymphoma

• Radiation therapy for localized lesions.
• Intralesional rituximab or topical steroids for low‑grade disease.
• Systemic chemo‑immunotherapy if disease is widespread.

General Comfort Measures

• Cool compresses for itching or burning.
• Moisturizers (fragrance‑free) to maintain skin barrier.
• Avoid scratching – use antihistamines (cetirizine 10 mg daily) if needed.

Prevention Tips

• Maintain good skin hygiene; keep areas dry and clean.
• Use antifungal powders or sprays if you have a history of tinea.
• Apply broad‑spectrum sunscreen (SPF 30+) daily to prevent photosensitive eruptions (e.g., lupus).
• Practice safe travel habits: wear protective clothing and insect repellent in leishmaniasis‑endemic regions.
• Control blood glucose; well‑managed diabetes reduces risk of necrobiosis lipoidica.
• Stay up‑to‑date with TB screening if you live or work in high‑risk settings.
• Avoid sharing personal items (towels, razors) that can transmit fungi.
• Promptly treat any skin injury; open wounds are portals for opportunistic infection.

Emergency Warning Signs

Key Take‑aways

Apple‑jelly skin rash is a visual cue that points clinicians toward a group of granulomatous, infectious, or inflammatory skin conditions. While the rash itself is not dangerous, the diseases behind it can range from self‑limited fungal infections to systemic tuberculosis or lymphoma. Recognizing associated symptoms, seeking prompt medical evaluation, and following evidence‑based treatment plans are essential for optimal outcomes.

References

• Mayo Clinic. “Tinea corporis (ringworm)”. https://www.mayoclinic.org. Accessed May 2026.
• CDC. “Cutaneous Leishmaniasis”. https://www.cdc.gov. Updated 2024.
• NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Granuloma Annulare”. https://www.niams.nih.gov. Accessed 2026.
• World Health Organization. “Tuberculosis – Cutaneous TB (Lupus vulgaris)”. https://www.who.int. 2023.
• Cleveland Clinic. “Sarcoidosis: Skin Involvement”. https://my.clevelandclinic.org. Reviewed 2025.
• American Academy of Dermatology. “Dermatofibroma”. https://www.aad.org. Accessed 2026.
• UpToDate. “Management of primary cutaneous B‑cell lymphoma”. 2024. (subscription required).

```